ANTARES PHARMA, INC. Insider Trading for June 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANTARES PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ANTARES PHARMA, INC. for June 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Option Exercise | A | 2.73 | 254,165 | 693,870 | 254,165 | |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Payment of Exercise | F | 2.78 | 8,564 | 23,808 | 630,065 | 638.6 K to 630.1 K (-1.34 %) |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Grant | A | 2.73 | 131,868 | 360,000 | 638,629 | 506.8 K to 638.6 K (+26.02 %) |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | A | 2.73 | 776,617 | 2,120,164 | 776,617 | |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.78 | 40,892 | 113,680 | 2,295,155 | 2.3 M to 2.3 M (-1.75 %) |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Grant | A | 2.73 | 402,930 | 1,099,999 | 2,336,047 | 1.9 M to 2.3 M (+20.84 %) |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Option Exercise | A | 2.73 | 254,165 | 693,870 | 254,165 | |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Payment of Exercise | F | 2.78 | 15,036 | 41,800 | 502,125 | 517.2 K to 502.1 K (-2.91 %) |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Grant | A | 2.73 | 131,868 | 360,000 | 517,161 | 385.3 K to 517.2 K (+34.23 %) |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | A | 2.73 | 77,662 | 212,017 | 77,662 | |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Grant | A | 2.73 | 40,293 | 110,000 | 253,042 | 212.7 K to 253 K (+18.94 %) |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | Greenleaf Peter | Director | Option Exercise | A | 2.73 | 58,246 | 159,012 | 58,246 | |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | Greenleaf Peter | Director | Grant | A | 2.73 | 30,220 | 82,501 | 54,193 | 24 K to 54.2 K (+126.06 %) |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 2.73 | 58,246 | 159,012 | 58,246 | |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Grant | A | 2.73 | 30,220 | 82,501 | 429,456 | 399.2 K to 429.5 K (+7.57 %) |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | ROCHE ROBERT P JR | Director | Option Exercise | A | 2.73 | 58,246 | 159,012 | 58,246 | |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | ROCHE ROBERT P JR | Director | Grant | A | 2.73 | 30,220 | 82,501 | 142,365 | 112.1 K to 142.4 K (+26.95 %) |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 2.73 | 58,246 | 159,012 | 58,246 | |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Grant | A | 2.73 | 30,220 | 82,501 | 224,406 | 194.2 K to 224.4 K (+15.56 %) |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | Smith Karen L. | Director | Option Exercise | A | 2.73 | 58,246 | 159,012 | 58,246 | |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | Smith Karen L. | Director | Grant | A | 2.73 | 30,220 | 82,501 | 54,193 | 24 K to 54.2 K (+126.06 %) |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | Smith Karen L. | Director | Option Exercise | A | 2.73 | 58,246 | 159,012 | 58,246 | |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | Smith Karen L. | Director | Grant | A | 2.73 | 30,220 | 82,501 | 54,193 | 24 K to 54.2 K (+126.06 %) |
| Jun 09 2020 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Payment of Exercise | F | 3.13 | 16,261 | 50,897 | 385,293 | 401.6 K to 385.3 K (-4.05 %) |
| Jun 09 2020 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Payment of Exercise | F | 3.12 | 17,994 | 56,141 | 401,554 | 419.5 K to 401.6 K (-4.29 %) |
| Jun 09 2020 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Payment of Exercise | F | 3.13 | 8,683 | 27,178 | 506,761 | 515.4 K to 506.8 K (-1.68 %) |
| Jun 09 2020 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Payment of Exercise | F | 3.12 | 9,609 | 29,980 | 515,444 | 525.1 K to 515.4 K (-1.83 %) |
| Jun 09 2020 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 3.13 | 44,223 | 138,418 | 1,933,117 | 2 M to 1.9 M (-2.24 %) |
| Jun 09 2020 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 3.12 | 48,936 | 152,680 | 1,977,340 | 2 M to 2 M (-2.42 %) |